Search Within

Miguel-Angel Perales

Formats
  1. Meeting Abstract (498)
  2. Journal Article (362)
  3. Review (29)
  4. Research Letter (18)
  5. Guidelines (12)
  6. Book Section (10)
  7. Editorial (6)
  8. Correspondence (5)
  9. Book Whole (1)
  10. Miscellaneous (1)
Groups
  1. Bone Marrow Transplant (942)
  2. Center for Hematologic Malignancies (942)
  3. Department of Medicine (942)
  4. Hematologic Malignancies, Division of (942)
  5. Survivorship Research (474)
  6. CTCR Scholars (411)

More Groups

People
  1. Sergio Giralt (428)
  2. Sean Devlin (302)
  3. Ann Jakubowski (247)
  4. Esperanza Papadopoulos (237)
  5. Gunjan Shah (204)
  6. Molly Maloy (196)

More People

Years
  1. 2025 (30)
  2. 2024 (76)
  3. 2023 (101)
  4. 2022 (95)
  5. 2021 (68)
  6. 2020 (93)

More Years

Publications
  1. Blood (264)
  2. Biology of Blood and Marrow Transplantation (220)
  3. Bone Marrow Transplantation (86)
  4. Transplantation and Cellular Therapy (68)
  5. Blood Advances (46)
  6. Journal of Clinical Oncology (32)

More Publications

Publishers
  1. American Society of Hematology (312)
  2. Elsevier Inc. (302)
  3. Nature Publishing Group (112)
  4. American Society of Clinical Oncology (32)
  5. Oxford University Press (18)
  6. John Wiley & Sons (17)

More Publishers

Results (942)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Excellent 3-year survival in recipients of mismatched unrelated donor transplants using post-transplant cyclophosphamide: Longer term outcomes of a national marrow donor program-sponsored prospective clinical trial
    Meeting Abstract

    Shaw, B.; Jimenez-Jimenez, A. M.; Burns, L.; Logan, B.; Khimani, F.; Shaffer, B.; Shah, N.; Mussetter, A.; Tang, X. Y.; McCarty, J.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • Toward improving diagnostic criteria for TA-TMA: Interim analysis of a multi-center retrospective review by the TA-TMA Working Group
    Meeting Abstract

    Rondon, G.; Giralt, S.; Boelens, J. J.; Cairo, M. S.; Champlin, R.; Duarte, R. F.; Hamadani, M.; Higham, C.; Ho, V. T.; Jerkins, J. H.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • Cost-effectiveness of axicabtagene ciloleucel as second-line therapy for patients large B-cell lymphoma (LBCL) in the United States
    Meeting Abstract

    Perales, M. A.; Kuruvilla, J.; Snider, J. T.; Vadgama, S.; Blissett, R.; El-Moustaid, F.; Smith, N.; Patel, A.; Johnston, P.
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • Outcomes of allogeneic HCT in patients with Hodgkin lymphoma in the era of checkpoint inhibitors: A joint CIBMTR and EBMT analysis
    Meeting Abstract

    Perales, M. A.; Awan, F.; Boumendil, A.; Chen, S.; Bazarbachi, A.; Finel, H.; Glass, B.; Herrera, A. F.; Kharfan-Dabaja, M.; Martinez, C.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • The cost-effectiveness of axicabtagene ciloleucel as second-line therapy in patients with large B-cell lymphoma in the United States: An economic evaluation of the ZUMA-7 trial
    Journal Article

    Perales, M. A.; Kuruvilla, J.; Snider, J. T.; Vadgama, S.; Blissett, R.; El-Moustaid, F.; Smith, N. J.; Patel, A. R.; Johnston, P. B.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Vitamin D insufficiency and clinical outcomes with chimeric antigen receptor T-cell therapy in large B-cell lymphoma
    Journal Article

    Nath, K.; Tomas, A. A.; Flynn, J.; Fein, J. A.; Alperovich, A.; Anagnostou, T.; Batlevi, C. L.; Dahi, P. B.; Fingrut, W. B.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • CD34-selected allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase era
    Research Letter

    Vaughn, J. L.; Brown, S.; Papadopoulos, E. B.; Jakubowski, A. A.; Tamari, R.; Giralt, S. A.; Ponce, D. M.; Cho, C.; Perales, M. A.; Shaffer, B. C.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • Characteristics of graft-versus-host disease (GvHD) after post-transplantation cyclophosphamide versus conventional GvHD prophylaxis
    Journal Article

    Saliba, R. M.; Alousi, A. M.; Pidala, J.; Arora, M.; Spellman, S. R.; Hemmer, M. T.; Wang, T.; Abboud, C.; Ahmed, S.; Antin, J. H.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Patterns of use, outcomes, and resource utilization among recipients of commercial axicabtagene ciloleucel and tisagenlecleucel for relapsed/refractory aggressive B cell lymphomas
    Journal Article

    Riedell, P. A.; Hwang, W. T.; Nastoupil, L. J.; Pennisi, M.; McGuirk, J. P.; Maziarz, R. T.; Bachanova, V.; Oluwole, O. O.; Brower, J.; Flores, O. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Infectious complications, immune reconstitution, and infection prophylaxis after CD19 chimeric antigen receptor T-cell therapy
    Review

    Wudhikarn, K.; Perales, M. A.
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save